OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 18.05.2026, 14:24

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Radiomics for the Prediction of Postoperative Chronic Kidney Disease in Renal Tumor Patients Undergoing Surgical Resection

2026·0 Zitationen·Urologia Internationalis
Volltext beim Verlag öffnen

0

Zitationen

9

Autoren

2026

Jahr

Abstract

INTRODUCTION: Chronic kidney disease (CKD) is a significant concern following renal tumor surgery, impacting long-term renal function and patient outcomes. This study investigated the potential of computed tomography (CT)-based radiomics as a quantitative imaging approach to predict postoperative CKD in kidney tumor patients. METHODS: We included adult patients with renal tumor surgery treated at our center between 2012 and 2022. Preoperative retrospective CT-imaging data were analyzed, and radiomic features were extracted from tumor lesions and renal parenchyma. Machine learning models were trained to predict postoperative new-onset CKD based on clinical information and radiomics. Model performance was assessed using five-fold cross-validation on the training set (n = 65) and on a separate test set (n = 17). Model performance was primarily evaluated using the receiver operating characteristic curve, with the area under the curve (AUC) serving as the principal summary metric. RESULTS: The study cohort comprised n = 82 patients, of whom n = 25 (30%) developed postoperative new-onset CKD. The best models achieved a mean validation AUC of 0.74 [95% CI: 0.60-0.86] for solely radiomics, 0.83 [0.73-0.93] with clinical information only, and 0.80 [0.67-0.91] on radiomics and clinical parameters, respectively (p > 0.05). For the test dataset, AUCs were 0.62 [95% CI: 0.29-0.92], 0.77 [0.50-0.98], and 0.80 [0.52-1.00], respectively (p > 0.05). CONCLUSION: Preoperative CT-based radiomic features in combination with clinical information can serve as a noninvasive predictor of postoperative CKD in renal tumor patients undergoing surgical resection. While prospective and external validation is needed, this approach facilitated clinical decision-making and enabled personalized treatment strategies in patients with renal tumors.

Ähnliche Arbeiten